Overview of the Market:
Asia Pacific Body Composition Analyzers Market was worth USD 76.26 million in 2018 and is projected to be growing at a CAGR of 16.5%, to touch USD 163.66 million by 2023. Body composition analyzers (BCAs) are devices which aid in measuring body composition. Body composition refers to the proportions of fat and lean mass present in the body.
The functioning of a Body Composition Analyzers involves measuring the percentages of fat, bone, water and muscle, present in the human body. BCAs are useful in determining leanness, since muscle mass takes up lesser space when compared to fat by weight, which makes it difficult to judge body fat without accurate measurements.
The growth of the Asia-Pacific Body Composition Analyzers Market is majorly driven by the increasing awareness among the people about the problems associated with obesity, and the benefits that come with maintainting appropriate fitness levels. Other factors driving the Asia-Pacific market include the rising use of BCAs in the sports and fitness industry and increasing governmental expenditure to increase awareness about physical activity and encourage health consciousness among the populace. However, high cost of the equipment and the inaccuracy of various analyzers are some of the constraints faced by the market.
The Global Body Composition Analyzers Market is segmented on the basis of Product, End-User and Region. Based on the Product, the Body Composition Analyzers market is allocated into Bio-impedance analyser, Dual Energy X-ray Absorptiometry (DEXA), Skinfold Callipers, Air Displacement Plethysmography (ADP) and Hydrostatic Weighing. On the basis of End User, the market is distributed among Hospitals, Fitness & wellness Centres, Academic & Research Centres and Home-users.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific Body Composition Analyzers Ma rket is expected to grow at the highest CAGR, due to the availability of massive untapped markets and enormous population base coupled with increasing health & fitness awareness, which is reflected in its robust CAGR of more than 16%. Factors such as growing disposable incomes and government support in countries such as India and China are expected to lead the growth of the market in this region.
The significant players in the Asia-Pacific Body Composition Analyzers Market include InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Bio-Impedance Analyzers
5.1.3 Dual Energy X-Ray Absorptiometry Equipment
5.1.4 Skinfold Callipers
5.1.5 Air Displacement Plethysmography
5.1.6 Hydrostatic Weighing Equipment
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Fitness Clubs and Wellness Centres
5.2.4 Academic & Research Centres
5.2.5 Home Users
5.2.6 Y-o-Y Growth Analysis, By End User
5.2.7 Market Attractiveness Analysis, By End User
5.2.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 InBody Co.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Tanita Corporation
8.3 Omron Corporation
8.4 Hologic
8.5 GE Healthcare
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
